Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2020

View Archived Issues

BMS details discovery and preclinical study of pulmonary fibrosis candidate BMS-986278

Blood substitution therapy expands therapeutic time window for stroke

iBET you I can kill those metastases

Elite controller achieves none-in-a-billion status

Efficacy and mechanism of action of novel DNA gyrase inhibitors against mycobacteria

Preclinical results suggest erectile dysfunction drugs can be repurposed to treat osteoporosis

FDA clears IND for global phase II study of CS-1001 for relapsed or refractory ENKTL

Cyprium reports topline clinical data for CUTX-101 in Menkes disease

Janssen Biotech patents DHODH inhibitors

U.S. researchers disclose new bacterial MenE inhibitiors

Skyhawk Therapeutics identifies small molecule splicing modulators for cancer

FDA expands EUA for Veklury to include hospitalized patients with mild or moderate COVID-19

Canwell Biotech synthesizes new TLR agonists

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Data presented on PF-05221304 and PF-06865571 coadministration in NAFLD patients

IIIM-290 development for treating pancreatic cancer advances into the clinic

TRILOGY 2 study of CaPre in severe hypertriglyceridemia does not meet primary endpoint

Akari details plans to develop nomacopan for COVID-19 pneumonia

Can-Fite's IND for phase II study of piclidenoson to treat COVID-19 cleared by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...